Result of General Meeting
05 Décembre 2007 - 2:05PM
UK Regulatory
RNS Number:2459J
EiRx Therapeutics PLC
05 December 2007
EIRX THERAPEUTICS PLC ("the Company")
Result of general meeting
At the general meeting of the Company held earlier today, all resolutions were
passed.
Application has been made for the re-admission of the Company's ordinary shares
to trading on AIM as Ordinary Shares of 0.001p with trading under the new
designation expected to commence on 6 December 2007.
With effect from re-admission the Company will have 2,975,743,260 Ordinary
Shares of 0.0001p each in issue.
For further information, please contact:
EiRx Therapeutics plc +353 (0)21 432 0847
Colin Telfer PhD, Chief Executive Officer
Grant Thornton Corporate Finance +44 (0)20 7383 5100
Philip Secrett / Colin Aaronson
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMXELFBDLBBFBZ
Eirx Therapeutics (LSE:ERX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Eirx Therapeutics (LSE:ERX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Eirx Therap. (London Stock Exchange): 0 recent articles
Plus d'articles sur Eirx Therapeutic Plc